** Drugmaker Cidara Therapeutics' shares rise 20.9% to $18.28
** CDTX raises $105 mln in private placement, co says
** Co says Venrock Healthcare Capital Partners and other life sciences-focused investors will purchase ~3.9 mln shares of CDTX at $14.912 per share
** Co also says certain investors will buy pre-funded warrants that would allow them to buy ~3.1 mln shares of CDTX at $14.9119 per share
** CDTX says it intends to use the funds for research and development, working capital and general corporate purposes
** All 5 brokerages rate the stock "buy" or higher; their median PT is $29 - LSEG
** Including session's gains, stock has risen 13.5% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。